Perfil
Philip Jochelson was Senior Vice President and Chief Medical Officer of Somaxon Pharmaceuticals, Inc. from April 2005 to March 4, 2009.
From November 1998 to March 2005, he worked for Neurocrine Biosciences, Inc. He held various positions in clinical development at Boehringer Ingelheim Canada and Alliance Pharmaceutical Corp.
Dr. Jochelson graduated from the University of Witwatersrand Medical School.
Antiguos cargos conocidos de Philip Jochelson.
| Empresas | Cargo | Fin |
|---|---|---|
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Director Técnico/Científico/I+D | 04/03/2009 |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Director Técnico/Científico/I+D | - |
Formación de Philip Jochelson.
| University of the Witwatersrand | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
Ocera Therapeutics, Inc. /Old/
Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Jochelson
